zidovudine has been researched along with Pneumococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brichacek, B; Janoff, EN; Pirruccello, S; Stevenson, M; Swindells, S | 1 |
| Gaday, I; Senegas, F; Sleth, JC | 1 |
2 other study(ies) available for zidovudine and Pneumococcal Infections
| Article | Year |
|---|---|
Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.
Topics: Adult; Anti-HIV Agents; Antibodies, Bacterial; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Progression; DNA, Viral; HIV Infections; HIV-1; Humans; Immunoglobulin G; Influenza Vaccines; Lymphocyte Activation; Middle Aged; Pneumococcal Infections; Polysaccharides, Bacterial; Proviruses; Receptors, Interleukin-2; RNA, Viral; Time Factors; Vaccination; Vaccines; Viral Load; Zidovudine | 1996 |
[Failure of anti-pneumococcal vaccination in a splenectomized patient with HIV infection].
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Humans; Immunosuppression Therapy; Pneumococcal Infections; Splenectomy; Treatment Failure; Vaccination; Zidovudine | 1998 |